FDA lets Philip Morris market Zyn pouches as less harmful than cigarettes

• The FDA ruling allows Zyn products to carry claims that switching from cigarettes reduces risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis
• The decision covers 20 Zyn products across 10 flavors (including Cool Mint, Cinnamon, and Coffee) in 3mg and 6mg nicotine strengths, building on January 2025 authorization that allowed sales but not health claims
• The approval follows lobbying from tobacco and vaping industries and aligns with Trump administration's policy shift toward supporting alternative nicotine products, including creating pathways for flavored products to remain on market

FDA Authorizes Philip Morris to Market Zyn Pouches as Less Harmful Than Cigarettes

Key Development:

The FDA approved Philip Morris-owned Zyn nicotine pouches to carry modified-risk claims on Tuesday, allowing the company to market 20 products as reducing risks of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis when users switch from cigarettes.

Products and Details:

The authorization covers 20 Zyn varieties including Chill, Cinnamon, Citrus, Coffee, Cool Mint, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen flavors in 3mg and 6mg nicotine strengths. This represents a significant upgrade from the FDA's January 2025 authorization, which permitted sales but not health-related marketing claims.

Market Implications:

This decision provides Philip Morris with a major competitive advantage in the fast-growing nicotine pouch market as traditional cigarette sales decline in the U.S. The company can now leverage specific health claims in marketing one of its key smoke-free products. Zyn pouches contain nicotine but no tobacco and have gained popularity among tech workers, conservatives, and users seeking cigarette alternatives.

Regulatory Context:

The ruling reflects the Trump administration's shift toward more industry-friendly tobacco policies after initially supporting flavored e-cigarette restrictions. The administration has created pathways for flavored products to remain on the market during FDA review, following intensive lobbying by tobacco and vaping industries. HHS Secretary Robert F. Kennedy Jr. reportedly uses nicotine pouches himself.

Public Health Concerns:

Critics warn that flavored pouches, social media promotion, and workplace acceptance could normalize nicotine use among non-smokers. The FDA emphasized that no tobacco product is safe and non-users should not start.